1. Sullivan PB. Peptic ulcer disease in children. Paediatrics and Child Health. 2010. 20:462–464.
Article
2. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet. 2002. 359:14–22.
Article
3. Hernández-Diaz S, Garcia-Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation. An overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000. 160:2093–2099.
Article
4. Pérez Gutthann S, GarciáRodríguez LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology. 1997. 8:18–24.
Article
5. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010. 24:121–132.
Article
6. Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994. 343:1075–1078.
Article
7. Holster IL, Kuipers EJ. Update on the endoscopic management of peptic ulcer bleeding. Curr Gastroenterol Rep. 2011. 13:525–531.
Article
8. Cappell MS. Therapeutic endoscopy for acute upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol. 2010. 7:214–229.
Article
9. Brown K, Lundborg P, Levinson J, Yang H. The incidence of peptic ulcer bleeding in the US pediatric population. J Pediatr Gastroenterol Nutr. 2012. 54:733–736.
10. Van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008. 22:209–224.
Article
11. Park JH. Medical treatment of peptic ulcer disease in children: role of H2RA, PPI. Korean J Pediatr Gastroenterol Nutr. 2007. 10:1 Suppl. 43S–52S.
12. Ramsoekh D, Van Leerdam ME, Rauws EAJ, Tygat GN. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection. Clin Gastroenterol Hepatol. 2005. 3:859–864.
Article
13. Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 1996. 312:1563–1566.
Article
14. Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective COX-2 inhibitors, traditional non-aspirin NSAIDs, aspirin, and combinations. Gut. 2006. 55:1731–1738.
Article
15. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991. 114:257–263.
Article
16. Hunt RH, Lanas A, Stichtenoth DO, Scarpignato C. Myths and facts in the use of antiinflammatory drugs. Ann Med. 2009. 41:423–437.
Article
17. O'Laughlin JC, Hoftiezer JW, Ivey KJ. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol Suppl. 1981. 67:211–214.
18. Manguso F, Riccio E, Nucci G, Aiezza ML, Amato G, Degl'Innocenti L, et al. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption. World J Gastroenterol. 2011. 17:4509–4516.
Article
19. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet. 2002. 359:14–22.
Article
20. Okan A, Tankurt E, Aslan BU, Akpinar H, Simsek I, Gonen O. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study. J Gastroenterol Hepatol. 2003. 18:18–25.
Article
21. Baxter M, Aly EH. Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010. 92:548–554.
Article
22. Chaer RA, Helton WS. Dieulafoy's disease. J Am Coll Surg. 2003. 196:290–296.
Article
23. Lee YT, Walmsley RS, Leong RW, Sung JJ. Dieulafoy's lesion. Gastrointest Endosc. 2003. 58:236–243.
Article
24. Senger JL, Kanthan R. The evolution of Dieulafoy's lesion since 1897: then and now-a journey through the lens of a pediatric lesion with literature review. Gastroenterol Res Pract. 2012. 2012:432517.
Article
25. Kay MH, Wyllie R. Therapeutic endoscopy for nonvariceal gastrointestinal bleeding. J Pediatr Gastroenterol Nutr. 2007. 45:157–171.
Article
26. Aabakken L. Current endoscopic and pharmacological therapy of peptic ulcer bleeding. Best Pract Res Clin Gastroenterol. 2008. 22:243–259.
Article
27. Fyock CJ, Draganov PV. Colonoscopic polypectomy and associated techniques. World J Gastroenterol. 2010. 16:3630–3637.
Article
28. Morris ML, Tucker RD, Baron TH, Song LM. Electrosurgery in gastrointestinal endoscopy: principles to practice. Am J Gastroenterol. 2009. 104:1563–1574.
Article
29. Chiu PW, Sung JJ. Acute nonvariceal upper gastrointestinal bleeding. Curr Opin Gastroenterol. 2010. 26:425–428.
Article
30. Chung IK, Lee DH, Kim HU, Sung IK, Kim JH. Korean College of Helicobacter and Upper Gastrointestinal Research. Korean Association of Gastroenterology. Guidelines of treatment for bleeding peptic ulcer disease. Korean J Gastroenterol. 2009. 54:298–308.
Article